Identification of new small molecules for selective inhibition of SERCA 1 in patient‐derived metastatic papillary thyroid cancer

Documenti analoghi

• IA‐0130, a novel 3‐(1,3‐diarylallylidene)oxindole derivative, alleviates ovarian cancer via inhibiting IL‐6/gp130/STAT3 signalling
  di: Sun‐Ae Park, et al.
  Pubblicazione: (2025)
• JAK–STAT inhibitory effect of IN‐115314, a novel small molecule inhibitor, and pharmacokinetic/pharmacodynamic study in canine
  di: Jae‐Hun Ahn, et al.
  Pubblicazione: (2025)
• Correction to “AQX‐1125, small molecule SHIP1 activator inhibits bleomycin‐induced pulmonary fibrosis”
  Pubblicazione: (2024)
• Inhibition of the upregulated phosphodiesterase 4D isoforms improves SERCA2a function in diabetic cardiomyopathy
  di: Zhenduo Zhu, et al.
  Pubblicazione: (2024)
• Paraoxonase‐2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non‐alcoholic steatohepatitis
  di: Gu‐Choul Shin, et al.
  Pubblicazione: (2024)